Crunching the numbers for CLBT... Refresh in a moment for the full analysis.
Cellebrite DI Ltd. (CLBT)
Technology
mixed
$11.03
Updated: 2026-04-12
Financial Strength
45
Mixed
Capital Allocation
50
Mixed
Key Findings
−
Piotroski F-Score 0–3 — multiple financial weakness signals
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.